Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Proteomics is the large-scale study of proteomes. A proteome is a collection of proteins produced in an organism, system, or biological context. For example, it can refer to the proteome of a species (for example, humans) or of an organ (for example, the liver). The proteome is not constant; it differs from cell to cell and changes over time. To some extent, the proteome reflects the underlying transcriptome.
Increase in pharmaceutical and biotechnological R&D spending and government funding of proteomics is the key factor driving the growth of the market along with increased growth of latest protocols and reagents used for the downstream evaluation to maximize DNA / RNA distortion from single cells test and increasing technological advancements are among the major factors driving the growth of the proteomics market. Additionally, increasing research and development activities in the market and an increase in technological advancement and modernization in healthcare techniques are expected to create more growth opportunities for the proteomics market during the forecast period.
Key factors driving the growth of the industry include the growing demand for personalized drugs and advanced diagnostics for targeted disease treatment and the high prevalence of target diseases. In addition, the growing focus on the use of products in drug design, biomarker discoveries, and clinical diagnostics for disease diagnosis and treatment is expected to support industry growth.
In addition, the global industry is expected to grow rapidly in the coming years due to technological advances, increased research funding, rising healthcare costs, increased demand for personalized medicines, and the growing number of various genetic diseases. The increasing prevalence of chronic diseases such as cancer, cardiovascular disease (CVD), respiratory disease, chronic kidney failure and others is another factor that should drive the growth of the market. For instance, according to Globocan, as of December 2020 there were 19.3 million new cancer cases worldwide and 10 million cancer deaths have been reported. Likewise, cardiovascular disease is a leading cause of death worldwide. For example, according to WHO (2021), target diseases kill 41 million patients per year. Therefore, due to the increasing prevalence of life-threatening diseases, the demand for personalized therapies is also increasing, which is expected to have a positive impact on the industry.
The market is expected to have new opportunities with the technological advancements and ongoing R&D involved in the proteomics sector is expected to provide ample new growth opportunities in the market during the forecast period. Opportunities related to the identification of biomarkers and developments in mass spectrometry-based proteomics are expected to provide lucrative growth opportunities for the growth of the proteomics market over the forecast period.
The market has major restraining factors like the high cost of proteomics instruments and the lack of advanced healthcare systems in developing nations. Also, the proteomics instruments include high investment and maintenance costs, and this factor is expected to act as a hurdler for the market’s growth over the forecast period. Besides, a lack of a skilled workforce is another factor which is expected to be a restraining factor for the growth of the market over the forecast period.
The COVID-19 pandemic has hampered the growth of the market to a major extent, which has created a major challenge for the market’s growth. Also, stringent regulatory standards are expected to be a major challenge for the market’s growth over the forecast period.
The report provides an in-depth analysis of the global Proteomics market, market size, and compound annual growth rate (CAGR) for the forecast period of 2022-2028, considering 2021 as the base year. The increasing demand for various Proteomics in various applications has led to the increasing demand for the market and is expected to witness growth at a specific CAGR from 2021-2028.
The global Proteomics market comprises of different market segments like product, technology, application and geography.
By product, the Proteomics market includes the key segments of
The reagents & consumables segment is expected to dominate the market over the forecast period. This is attributed to the extensive use of reagents and consumables, kits, chemicals, and strips for the examination of various biological samples in academic institutions, research laboratories, and others, which will increase the demand for reagents and consumables, which will drive the growth of the segment. Furthermore, technological developments of advanced tools, such as 2-D electrophoresis protein analyzers, which improve the speed, efficiency, and productivity of biological research, would also support market growth.
Electrophoresis equipment and biochip analyzers are the most commonly used tools for protein analysis. In addition, the growing demand for automation in diagnostic techniques and the need for an affordable platform for sample analysis have increased manufacturers' interest in focusing on innovations and product development. Furthermore, technological innovations (the increasing scaling and integration of biochips and advances in mass spectrometry tools and workflows) in proteomics tools are expected to drive market trends in the coming years.
By technology, the Proteomics market is segmented into
The spectroscopy segment is expected to have the fastest growth over the forecast period. Key drivers driving the segment's growth include the massive use of spectroscopy-based technologies used in many analytical applications, including drug development, proteomics, metabolomics, forensic and pharmaceutical analysis processes. In recent years, this method has been used more widely at various stages of the drug development process.
An increase in the use of microarrays in various applications is expected to complement the growth of the industry. For example, the use of microarray analysis in antibiotic therapy has proven effective, as in most cases the bacterial genomic DNA survives the survival of the bacteria. Recently, the preferred technique for determining gene expression has been the use of DNA-based microarrays. This is mainly due to elements such as complexity and cost reduction that make the technology more widely available and uniform.
The Proteomics market has major applications like
The clinical diagnostics segment is expected to dominate the market over the forecast period. This is attributed to the high acceptance of protein analysis among clinical researchers to identify disease biomarkers for early disease detection and the identification of individual risk factors. This is expected to create new opportunities for disease prevention and early intervention. With the help of proteomics-based diagnosis, it is possible to uncover potential biomarkers and protein expression patterns that can be used to classify and predict tumors and determine their prognosis, thereby aiding in segment growth.
On the other hand, the drug discovery segment is estimated to register the fastest growth rate over the projected period. The development of structure-based drug design, a greater emphasis on creating personalized drugs, and greater investments in these areas can all be attributed to the growth of the segment. Additionally, proteomics technologies also provide a way to prove themselves at the start of a drug discovery program, saving pharmaceutical companies a significant amount of capital and ultimately benefiting both patients and healthcare systems by contributing to the growth of the segment.
The global Proteomics market is studied for the following regions
The North American region is expected to lead the market over the forecast period. This is attributed to increased investment in structure-based drug design development, growth from omics research, to the demand for high-quality research tools for data reproducibility; and to the attention given to the development of personalized treatments. The expansion of this market is also favoured by partnerships and collaborations between large companies in this region.
The Asia-Pacific region is estimated to experience the fastest CAGR over the estimated time period due to an increase in outsourcing of proteomics-based projects, public and private funding of R&D for proteomics studies, favourable government regulations, the increasing prevalence of target diseases and aging population and the growing adoption of proteomics.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360-degree analysis of micro and macro-economic factors on the global Proteomics market. In addition, a complete analysis of changes in the global Proteomics market expenditure, economic and international policies on the supply and demand side. The report also studies the impact of the pandemic on global economies, international trade, business investments, GDP, and marketing strategies of key players present in the market.
The COVID-19 outbreak has negatively impacted various healthcare-related markets. This pandemic is expected to provide opportunities for growth in the future. The development of therapeutic and preventive strategies requires a thorough understanding of the roles played by proteins in the infection process of SARS-CoV-2 and in the progression of COVID-19. A wide range of identification and separation techniques can isolate proteins from complex mixtures, facilitating analysis of protein-protein interactions, temporal patterns of expression, and cellular or subcellular distribution. For example, the most common separation methods are one-dimensional and two-dimensional gel electrophoresis and high-performance liquid chromatography, while mass spectrometry (MS) forms the backbone for the detection and identification of proteins. Protein identification using MS techniques has overcome the limitations of other proteomics technologies (including 2D gel electrophoresis) which require large amounts of purified proteins for analysis. MS-based viral peptide detection has previously been used to profile viral proteins affecting the airways. Currently, reverse transcription polymerase chain reaction (RT-PCR) is the primary method for detecting viral genes in COVID-19 positive patients.
The competitive landscape analysis of the Proteomics market is majorly focused on expanding the global growth of Proteomics with new product innovation, business expansion, and the increasing presence of a range of manufacturers operating in the proteomics industry has led to the growing demand for the market. Besides, the market offers a range of products in different applications to fulfil the consumer’s requirements, which is further contributing towards healthy growth in the market.
The key players studied in market are
March 2022: Thermo Fisher Scientific and Symphogen announced the continuation of their collaboration to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterization of complex therapeutic proteins.
June 2021: Bruker Corp. launched two new timsTOF instruments. It enables new methods and applications, such as epiproteomics/PTM characterization, and multi-omic biomarker discovery.
By product, the Proteomics market includes the key segments of Instruments, Reagents and Consumables and Services. The reagents & consumables segment is expected to dominate the market over the forecast period. By technology, the Proteomics market is segmented into microarray instruments, x-ray crystallography, spectroscopy, chromatography, protein fractionation systems, electrophoresis and surface plasma resonance (SPR) systems. The spectroscopy segment is expected to have the fastest growth over the forecast period. The Proteomics market has major applications like drug discovery, clinical diagnostics and others. The clinical diagnostics segment is expected to dominate the market over the forecast period due to the high acceptance of protein analysis among clinical researchers to identify disease biomarkers for early disease detection and identification of individual risk factors. The global Proteomics market is studied for the following regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). North American region is expected to lead the market over the forecast period.
| Market Sizing for Year: | 2019-2028 |
| Base Year: | 2021 |
| Forecast Period: | 2022-2028 |
| Value: | USD
million |
| Market Segment studied: | Product Technology Application |
| Market Players and its
Competitors: | Bio-Rad Laboratories, Inc. Illumina, Inc. Agilent Technologies, Inc. Danaher Corporation General Electric Thermo Fisher Scientific,
Inc. Bruker Corporation F. Hoffmann-La Roche Ltd. Promega Corp. Merck KGaA Biognosys AG Bruker Caprion Biosciences Inc. Luminex Corporation Genzyme Corporation LI-COR, Inc. |
FREQUENTLY ASKED QUESTIONS
What would be forecast period in the market report?
2022-2088 is the forecast period in the market report.
Which is the leading application segment for Proteomics market?
The clinical diagnostics segment has accounted the major market share, and is expected to witness the growth at highest pace during the forecast period.
Which region is gaining majority of market share during the forecast period (2022-2028)?
North America is expected to gain major market share during the forecast period (2022-2028).
